HMC Capital Ltd (ASX: HMC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

HMC Capital Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.26 billion
P/E Ratio 8.52
Dividend Yield 3.86%
Shares Outstanding 412.62 million
Earnings per share 0.365
Dividend per share 0.12
Year To Date Return -20.96%
Earnings Yield 11.74%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • HMC Capital Ltd (ASX: HMC)
    Latest News

    Three people skydiving.
    Dividend Investing

    1 ASX dividend stock down 77% I'd buy right now

    I believe this business is significantly undervalued…

    Read more »

    A young smiling couple out hiking enjoy a view from the top of the mountains.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a bumpy but positive start to the trading week today.

    Read more »

    A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
    Share Fallers

    These were the worst-performing ASX 200 shares in September

    These shares were sold off in September, but why?

    Read more »

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
    Broker Notes

    Morgans says these ASX shares could rise 20% to 30%

    Which shares is the broker bullish on? Let's dig deeper into things.

    Read more »

    Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    ASX shares finally reversed their losses today.

    Read more »

    2 street signs with winner and loser COVID recovery oil price
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a happy end to the trading week today.

    Read more »

    Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
    Cheap Shares

    3 Australian value stocks to buy when everyone else is selling

    Analysts think these beaten down shares could be buys.

    Read more »

    A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
    Dividend Investing

    16 ASX 200 shares going ex-dividend next week

    Time is now critical if you want to invest in these ASX shares while they are trading cum dividend.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    Here's what brokers are recommending as buys this week.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a decently positive hump day for the markets today.

    Read more »

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Share Gainers

    Why HMC Capital, Lottery Corp, Magellan, and Stockland shares are racing higher today

    These shares are having a good time on hump day. But why?

    Read more »

    Bored man sitting at his desk with his laptop.
    Share Fallers

    Why CSL, HMC Capital, Reliance, and Suncorp shares are sinking today

    These shares are having a difficult time on Tuesday. But why?

    Read more »

    Frequently Asked Questions

    Yes, HMC Capital has historically paid largely fully franked shareholder dividends twice a year.

    HMC Capital generally pays its shareholder dividends in April and October.

    HMC Capital Ltd listed on the ASX on 14 October 2019.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Aug 2025 $0.0600 0.00% Final 30 Sep 2025
    25 Feb 2025 $0.0600 100.00% Interim 01 Apr 2025
    27 Aug 2024 $0.0600 70.00% Final 02 Oct 2024
    26 Feb 2024 $0.0600 0.00% Interim 02 Apr 2024
    29 Aug 2023 $0.0600 10.00% Final 04 Oct 2023
    01 Mar 2023 $0.0600 100.00% Interim 06 Apr 2023
    01 Sep 2022 $0.0600 100.00% Final 07 Oct 2022
    01 Mar 2022 $0.0600 100.00% Interim 07 Apr 2022
    02 Sep 2021 $0.0600 50.00% Final 01 Oct 2021
    02 Mar 2021 $0.0600 100.00% Interim 17 Mar 2021
    03 Sep 2020 $0.0750 100.00% Final 18 Sep 2020
    04 Mar 2020 $0.0450 100.00% Interim 19 Mar 2020

    HMC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About HMC Capital Ltd

    HMC Capital Ltd (ASX: HMC) is an ASX-listed property company focusing on ownership, development, and management of real estate assets. HMC currently has more than $7.5 billion of assets under management (AUM) across real estate and private equity strategies. It is also looking to bolster opportunities in energy transition, value-add infrastructure, and private credit. Two listed real estate investment trusts (REITs) operate under the company structure as well as several unlisted funds.

    HMC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Feb 2026 $3.06 $-0.07 -2.24% 2,007,927 $3.05 $3.11 $3.02
    19 Feb 2026 $3.13 $-0.02 -0.63% 1,990,417 $3.15 $3.17 $3.00
    18 Feb 2026 $3.15 $0.09 2.94% 3,695,288 $3.13 $3.18 $3.08
    17 Feb 2026 $3.06 $-0.07 -2.24% 2,358,586 $3.09 $3.10 $3.02
    16 Feb 2026 $3.13 $0.02 0.64% 2,315,451 $3.13 $3.18 $3.05
    13 Feb 2026 $3.11 $-0.21 -6.33% 2,813,945 $3.29 $3.29 $3.10
    12 Feb 2026 $3.32 $-0.28 -7.78% 3,089,416 $3.62 $3.63 $3.30
    11 Feb 2026 $3.60 $-0.14 -3.74% 1,890,500 $3.74 $3.75 $3.59
    10 Feb 2026 $3.74 $0.02 0.54% 2,450,908 $3.75 $3.91 $3.68
    09 Feb 2026 $3.72 $-0.20 -5.10% 8,337,515 $4.02 $4.09 $3.69
    06 Feb 2026 $3.92 $-0.11 -2.73% 14,933,436 $4.10 $4.34 $3.73
    05 Feb 2026 $4.03 $0.00 0.00% 1,839,382 $4.03 $4.10 $3.98
    04 Feb 2026 $4.03 $-0.22 -5.18% 1,255,497 $4.25 $4.26 $4.02
    03 Feb 2026 $4.25 $0.06 1.43% 1,079,912 $4.22 $4.27 $4.13
    02 Feb 2026 $4.19 $-0.01 -0.24% 827,779 $4.15 $4.26 $4.12
    30 Jan 2026 $4.20 $-0.02 -0.47% 1,940,912 $4.20 $4.39 $4.12
    29 Jan 2026 $4.22 $0.05 1.20% 1,013,383 $4.17 $4.22 $4.07
    28 Jan 2026 $4.17 $0.04 0.97% 2,198,291 $4.27 $4.36 $4.13
    27 Jan 2026 $4.13 $-0.19 -4.40% 1,694,300 $4.32 $4.32 $4.00
    23 Jan 2026 $4.32 $0.16 3.85% 620,367 $4.16 $4.35 $4.16
    22 Jan 2026 $4.16 $0.11 2.72% 1,188,302 $4.13 $4.22 $4.08

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Nov 2025 Christopher Roberts Issued 17,120 $60,776
    Director remuneration. 17,120 rights
    27 Nov 2025 Gregory (Greg) Hayes Issued 15,692 $55,706
    Director remuneration. 21,393 rights
    27 Nov 2025 Fiona Pak-Poy Issued 15,692 $55,706
    Director remuneration. 15,692 rights
    27 Nov 2025 David Di Pilla Issued 595,924 $2,115,530
    Issue of securities. 1,639,348 performance rights
    27 Nov 2025 Christopher Saxon Issued 35,666 $126,614
    Director remuneration. 35,666 rights
    27 Nov 2025 Kelly O'Dwyer Issued 21,400 $75,970
    Director remuneration. 21,400 rights
    27 Nov 2025 Susan Roberts Issued 19,972 $70,900
    Director remuneration. 19,972 rights
    21 Nov 2025 Kelly O'Dwyer Buy 32,959 $104,761
    On-market trade. 1000 Prior Holding
    30 Sep 2025 David Di Pilla Expiry 179,616 $571,178
    As advised by the company. Lapsed, 10,43,424 Rights
    05 Sep 2025 David Di Pilla Buy 367,783 $1,316,663
    On-market trade.
    04 Sep 2025 David Di Pilla Buy 200,120 $684,410
    On-market trade.
    20 Aug 2025 David Di Pilla Buy 1,346,181 $5,021,913
    On-market trade.
    20 Aug 2025 Christopher Saxon Exercise 8,036 $30,938
    Conversion of securities.
    20 Aug 2025 Christopher Saxon Buy 8,036 $30,938
    Conversion of securities.
    20 Aug 2025 Fiona Pak-Poy Buy 3,621 $13,940
    Conversion of securities.
    20 Aug 2025 Fiona Pak-Poy Exercise 3,621 $13,940
    Conversion of securities.
    20 Aug 2025 Gregory (Greg) Hayes Buy 3,536 $13,613
    Conversion of securities.
    20 Aug 2025 Gregory (Greg) Hayes Exercise 3,536 $13,613
    Conversion of securities. 5,701 rights
    20 Aug 2025 Christopher Roberts Exercise 3,952 $15,215
    Conversion of securities.
    20 Aug 2025 Christopher Roberts Buy 3,952 $15,215
    Conversion of securities.
    20 Aug 2025 Susan Roberts Buy 4,500 $17,325
    Conversion of securities.
    20 Aug 2025 Susan Roberts Exercise 4,500 $17,325
    Conversion of securities.
    20 Aug 2025 Kelly O'Dwyer Exercise 4,179 $16,089
    Conversion of securities.
    20 Aug 2025 Kelly O'Dwyer Buy 4,179 $16,089
    Conversion of securities.
    22 May 2025 David Di Pilla Sell 10,845,709 $57,048,429
    As advised by the company. Distribution of shares to HICT unitholder as part of a transaction under which the unitholder redeemed their units in HICT. As per announcement on 26-05-2025
    09 Apr 2025 Christopher Roberts Buy 66,812 $311,343
    As advised by the company. Acquisition of fully paid ordinary shares on market.
    08 Apr 2025 Christopher Roberts Buy 86,812 $410,620
    As advised by the company. Acquisition of fully paid ordinary shares on market

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Nov 2024
    Dr Roberts has over 40 years of experience in the medical device industry serving a number of senior management positions. He was the former CEO of Cochlear from 2004 to 2015 and is presently a member of the Cochlear Foundation Board, Non-Executive Director of HCW Funds Management Limited, HMC Capital Partners Fund 1, Atmo Biosciences Ltd, Centenary Institute of Medical Research and Nutromics Pty Ltd. He was also the Executive Vice President of ResMed from 1992 to 2003, and a director until 2017. He was a former Chair of Research Australia from 2004 to 2010. He is member of the risk committee.
    Mr Gregory (Greg) John Hayes Non-Executive Director Sep 2019
    Mr Hayes is currently a Non-Executive Director of Aurrum Holdings Pty Ltd and Secure AI Pty Ltd. Having worked across a range of industries including property, infrastructure, energy and logistics, his skills and experience include strategy, finance, mergers and acquisitions and strategic risk management, in particular in listed companies with global operations. He was previously Chief Financial Officer and Executive Director of Brambles Limited, Chief Executive Officer and Group Managing Director of Tenix Pty Ltd, Chief Financial Officer and later interim Chief Executive Officer of the Australian Gaslight Company, Chief Financial Officer Australia and New Zealand of Westfield Holdings, Executive General Manager, Finance of Southcorp Limited. He is a member of Risk Committee.
    Ms Fiona Jane Pak-Poy Non-Executive Director Nov 2024
    Ms Pak Poy is Non-Executive Director of Silicon Quantum Computing Pty Ltd and Kain Lawyers Pty Ltd. She is on the Board of Trustees and Investment Committee for HMC Capital Partners Fund 1 and is a member of the Business Advisory Council for Anacacia Capital. She has over 30 years of experience in a variety of industries, for companies ranging from startups to listed companies, government entities and not-for-profits. She has served on various boards, including, MYOB, Isentia, Novotech, PageUp People, StatePlus and SIRCA (the Securities Research Centre of South-East Asia). She served on the ASIC director Advisory Panel and the Board of Innovation Australia. Previously she was a strategy consultant for the Boston Consulting Group in the US and Australia and was a General Partner in an Australian venture capital fund focused on technology startups. She is Member of the Sustainability Committee.
    Mr David Anthony Di Pilla Chief Executive OfficerExecutive DirectorManaging Director Oct 2017
    Mr Pilla led the team that founded the consortium which led to the ultimate establishment HMC Capital in 2016. Since this time, the HMC Group has grown from its initial Masters portfolio to today being a diversified alternative asset manager. He has over 30 years of experience in investment banking, strategic advisory & consulting and corporate leadership as a Director and CEO. During his 20-year investment banking career he was Managing Director of UBS Investment Bank for over 15 years and during this time led some of Australias landmark transactions across corporate M&A, Equity & Debt Capital Markets. Prior to his time at UBS, he reached the position of Vice President, Investment Banking at JP Morgan.
    Mr Christopher Saxon Non-Executive DirectorNon-Executive Chairman Sep 2019
    Mr Saxon was, until 2019, a partner with global law firm Baker McKenzie. His practice included large scale mergers and acquisition transactions across a range of sectors, notably energy (gas, electricity, renewable), industrials, infrastructure and mining. He has been ranked as one of Australias foremost project and M&A lawyers and has been lead adviser on government restructuring transactions and privatisations, major trade sales and infrastructure projects. He served as Chair of Baker McKenzie Australia for five years (2012-2017) and held numerous leadership roles within the firm.
    Hon Kelly Megan O'Dwyer Non-Executive Director Nov 2020
    Hon O Dwyer is a Non-Executive Director of EQT Holdings Limited, HealthCo Healthcare and Wellness REIT, DigiCo Infrastructure REIT, Barrenjoey Capital Partners Group Holdings Pty Ltd and the National Reconstruction Fund Corporation. She previously served in the Australian Parliament as a Senior Cabinet Minister holding a number of key economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She also served on the Cabinets Budget Committee (the Expenditure Review Committee) and held the portfolios of Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. Prior to entering Parliament, she worked in law, government and finance and brings insights across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is Chair of Sustainability Committee, Member of the Risk Committee.
    Ms Susan Roberts Non-Executive Director Nov 2022
    Ms Roberts is an experienced director and CEO with over 30 years in the financial services, investment and insurance industries. Her current roles include Chair of Audit for AIG Australia and Teachers Health, and she is a director of Metlife Australia. She has commercial and financial executive experience, including CEO and Managing Director of Lazard Asset Management Pacific, and Director, Strategy at Lend Lease Investment Services. She has previously served as a Non-Executive Director of Maple Brown Abbott and as Chair of the Audit and Risk, and Claims Committee for Zurich Australia Superannuation. Susan was also Chair of the Investor Working Group for the 30% Club in Australia. She is Member of the Sustainability Committee.
    Mr Andrew Selim Company SecretaryGeneral Counsel
    -
    Andrew Selim Company SecretaryGeneral Counsel
    -
    Will McMicking Group Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 138,856,111 33.98%
    Home Investment Consortium Trust 79,535,204 19.47%
    J P Morgan Nominees Australia Pty Limited 47,317,554 11.58%
    Citicorp Nominees Pty Limited 35,847,791 8.77%
    Goat Properties Pty Ltd 12,853,001 3.15%
    National Nominees Limited 7,762,252 1.90%
    Aurrum Holdings Pty Ltd 7,023,606 1.72%
    BNP Paribas Nominees Pty Ltd 4,719,004 1.15%
    Netwealth Investments Limited 4,031,608 0.99%
    UBS Nominees Pty Ltd 3,280,022 0.80%
    BNP Paribas Noms Pty Ltd 2,484,927 0.61%
    CW Property Nominees Pty Ltd 2,238,806 0.55%
    BNP Paribas Noms Pty Ltd 1 2,089,200 0.51%
    Pacific Custodians Pty Limited 1,513,230 0.37%
    Aldaoud Pty Ltd 1,300,000 0.32%
    SG Foundation Investments Pty Ltd 1,071,014 0.26%
    BNP Paribas Noms Pty Ltd 2 989,575 0.24%
    HSBC Custody Nominees (Australia) Limited 1 945,553 0.23%
    BNP Paribas Noms Pty Ltd 3 868,483 0.21%
    Doux Argent Pty Ltd 743,301 0.18%

    Profile

    since

    Note